VIVUS Inc (VVUS)

2.79 -0.09  -3.12% NASDAQ Nov 21, 16:59 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
02/26/2020 16:30 EST Misc VIVUS Inc Fourth Quarter Earnings Conference Call in 2019
02/26/2020 Earnings VIVUS Inc Fourth Quarter Earnings in 2019 Release
11/05/2019 16:30 EST Misc VIVUS Inc Third Quarter Earnings Conference Call for 2019
11/05/2019 Earnings VIVUS Inc Third Quarter Earnings in 2019 Release
08/06/2019 16:30 EDT Misc VIVUS Inc Second Quarter Earnings Conference Call in 2019
08/06/2019 Earnings VIVUS Inc Second Quarter Earnings in 2019 Release
06/05/2019 Misc VIVUS Inc Annual General Meeting in 2018
04/30/2019 16:30 EDT Misc VIVUS Inc First Quarter Earnings Conference Call in 2019
04/30/2019 Earnings VIVUS Inc First Quarter Earnings in 2019 Release
02/26/2019 16:30 EST Misc VIVUS Inc Fourth Quarter Earnings Conference Call in 2018
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.vivus.com
  • Investor Relations URL: http://ir.vivus.com/
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Value
  • Next Earnings Release: Feb. 26, 2020
  • Last Earnings Release: Nov. 05, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: VIVUS Inc is a US-based biopharmaceutical company engaged in developing and commercializing, next-generation therapies to address unmet medical needs in human health. Its commercial products include Qsymia, an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index; PANCREAZE which is a is a pancreatic enzyme preparation consisting of pancrelipase, an extract derived from porcine pancreatic glands, as well as other enzyme classes and Stendra/Spedra, which is an oral phosphodiesterase type 5 inhibitor for the treatment of erectile dysfunction. The company operates through the single segment of business being Development and commercialization of novel therapeutic products.

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.